Cyrill A. Rentsch - Concepedia

Author

Cyrill A. Rentsch

Also Known As

C A Rentsch, C Rentsch, C. A. Rentsch, C. Rentsch, C.A. Rentsch, CA Rentsch, CYRILL RENTSCH, Christian Ruiz, Cyril A. Rentsch, Cyril Rentsch

241

Publications

3.7K

Citations

H-Index

Concepts

All Affiliations

University Hospital of Basel University of Bern University of Basel University Hospital of Bern St. Claraspital

About

Cyrill A. Rentsch is an author at University Hospital of Basel specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	20	1.3K
2	Cell Biology	5	5	407
3	Engineering	1	1	49
4	Health Sciences	1	1	61
5	Biostatistics	1	1	49

Cyrill A. Rentsch

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Preexisting BCG-Specific T Cells Improve Intravesical Immunotherapy for Bladder Cancer Claire Biot, Cyrill A. Rentsch, Joël Gsponer, Science Translational Medicine	2012	265
ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence Mathieu F. Chevalier, Sara Trabanelli, Julien Racle, Journal of Clinical Investigation ImmunologyImmune RegulationPathologyBladder Cancer RecurrenceImmunoediting	2017	212
A retrospective analysis of 153 patients treated with or without intravesical bacillus Calmette-Guerin for primary stage T1 grade 3 bladder cancer: recurrence, progression and survival. Osama Shahin, George N. Thalmann, Cyrill A. Rentsch, PubMed	2003	209
A Retrospective Analysis of 153 Patients Treated With or Without Intravesical Bacillus Calmette-Guerin for Primary Stage T1 Grade 3 Bladder Cancer: Recurrence, Progression and Survival Osama Shahin, George N. Thalmann, Cyrill A. Rentsch, The Journal of Urology	2003	208
Bone Morphogenetic Protein 7 in the Development and Treatment of Bone Metastases from Breast Cancer Jeroen T. Buijs, Nico V. Henriquez, Petra G.M. van Overveld, Cancer Research	2007	201
BMP7, a Putative Regulator of Epithelial Homeostasis in the Human Prostate, Is a Potent Inhibitor of Prostate Cancer Bone Metastasis in Vivo Jeroen T. Buijs, Cyrill A. Rentsch, Geertje van der Horst, American Journal Of Pathology UrologySclerostinHuman ProstateBone Morphogenic ProteinEpithelial Homeostasis	2007	199
Bacillus Calmette-Guérin Strain Differences Have an Impact on Clinical Outcome in Bladder Cancer Immunotherapy Cyrill A. Rentsch, Frédéric D. Birkhäuser, Claire Biot, European Urology Urological ResearchUrologyGenitourinary CancerMedicinePathology	2014	187
URINARY INTERLEUKIN-8 AND 18 PREDICT THE RESPONSE OF SUPERFICIAL BLADDER CANCER TO INTRAVESICAL THERAPY WITH BACILLUS CALMETTE-GUERIN George N. Thalmann, Alain Sermier, Cyrill A. Rentsch, The Journal of Urology	2000	142
Lack of Noggin Expression by Cancer Cells Is a Determinant of the Osteoblast Response in Bone Metastases Ruth Schwaninger, Cyrill A. Rentsch, Antoinette Wetterwald, American Journal Of Pathology SclerostinBone Morphogenic ProteinMedicineOsteoblast ResponseCell Death	2007	94
In vitro propagation and characterization of neoplastic stem/progenitor‐like cells from human prostate cancer tissue Natalia Guzmán‐Ramírez, Maureen Völler, Antoinette Wetterwald, The Prostate	2009	90

Page 1